You are here: Industry Insights > infectious diseases

News List

Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy prnasia
September 28, 2021
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens...
Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective response expresspharma
October 10, 2020
The research published in Nature focuses on the role of the Fc domain of monoclonal antibodies, regions with the capacity to bind to other immune cells through a family of receptors.
Noscendo Closes Series A Financing and Launches DISQVER® in Europe to Significantly Improve Diagnosis of Infectious Diseases b3cnewswire
April 23, 2020
Noscendo GmbH, a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections, today announced the commencement of operations in its own development and application laboratory as well as the c
A wake-up call for One Health expresspharma
April 01, 2020
As an important stakeholder of global health security, it is time for the pharma sector to embrace newer approaches and strategies which are in line with One Health principles to be a worthy warrior in the war against zoonoses.
National Centre for Infectious Diseases opens in Singapore biospectrumasia
September 10, 2019
National Centre for Infectious Diseases (NCID) has officially opened in Singapore that replaces the old Communicable Disease Centre (CDC).
Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance americanpharmaceuticalreview
August 22, 2019
The Pfizer Foundation has announced 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases ...
Gilead, AbCellera team up against infectious diseases pharmatimes
June 16, 2019
AbCellera has announced a partnership with Gilead to discover antibodies for infectious disease.
Gilead launches generics of own hepatitis C drugs in US to cut health costs pharmaphorum
September 27, 2018
Gilead is to launch cheaper generic versions of its hepatitis C drugs in the US, responding to calls for lower drug prices because of spiralling healthcare costs.
Emergex Vaccines receives grant for universal flu vaccine programme biospectrumasia
May 15, 2018
Emergex’s vaccine combines several proprietary technologies to create an immune response based on ‘reverse engineering’
Algorithm proves its worth in preventing spread of infectious diseases europeanpharmaceuticalreview
February 28, 2018
Scientists in California have undertaken studies that have demonstrated the effectiveness of a sophisticated algorithm in preventing the spread of infectious diseases.